A defined communication purpose
Each asset has an audience, decision, approved evidence base and clear promotional or educational status.
Pharma and life sciences
We help teams connect market understanding, stakeholder needs, approved claims, content operations and digital journeys while keeping promotional and non-promotional purposes distinct.
Each asset has an audience, decision, approved evidence base and clear promotional or educational status.
Web, field, professional and patient materials use consistent language and a governed source of claims.
Teams can see whether content reaches the intended audience and supports the next appropriate action.
Patient, caregiver, professional, payer, partner and internal perspectives relevant to the programme.
Audience needs, role of the brand or programme, claim hierarchy, evidence and required qualification.
Websites, portals and content journeys designed around audience eligibility, purpose and appropriate access.
Briefs, references, versioning, review workflow, expiry and reuse across markets or channels.
Distinct information needs, literacy levels, risk context and calls to action for each audience.
Engagement and progression measures that respect consent, audience restrictions and sensitive-data requirements.
Clarify country, audience, product status, programme purpose and approval requirements.
Connect each communication objective to approved source material and ownership.
Create the smallest useful set of journeys and assets for the target audiences.
Use review outcomes and audience behaviour to improve clarity without bypassing approval.
We examine what people search for, the questions they ask and the alternatives they compare. Internal assumptions are useful hypotheses, not substitutes for demand evidence.
Service mix, clinician capacity, locations, lead times, economics and referral patterns shape the plan. Marketing should not create demand the organisation cannot serve well.
We look beyond the channel to the landing page, evidence, enquiry route, call handling, scheduling and the reasons people do not proceed.
Clinical and product claims require substantiation and jurisdiction-specific review. Measurement and tracking choices must be appropriate for sensitive health data.
The measurement plan depends on the business model, but it does not end with traffic, impressions or submitted forms.
Connected capabilities
Tell us about the organisation, the priority service line and the outcome that needs to change.